Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: JCI Insight. 2016 May 19;1(7):e86873. doi: 10.1172/jci.insight.86873

Table 2.

MCJ expression in relation to clinical markers

Characteristic MCJ expression fold-change (mean, SD) P valueA
Age 0.41
 ≤40 5.75 (4.5)
 41–50 3.36 (1.9)
 51–60 4.38 (3.0)
 60+ 1.30 (1.3)
Cancer stage 0.59
 IIA 5.13 (5.0)
 IIB 2.75 (2.5)
 IIA/IIIB 4.06 (2.1)
Nottingham grade 0.57
 1 3.35 (0.1)
 2 3.24 (2.1)
 3 5.08 (4.4)
Tumor subtypes 0.69
 Basal 3.10 (2.6)
 HER2 5.97 (5.5)
 Luminal A 3.58 (3.8)
 Luminal B 0.9 (0)
 Luminal B-like 4.38 (0.4)
A

P values based on 1-way ANOVA.